ProQR Therapeutics N.V. buy Citigroup Inc.
Start price
19.04.24
/
50%
€1.78
Target price
19.04.25
€1.88
Performance (%)
-3.93%
Price
04.09.24
€1.71
Summary
This prediction is currently active. With a performance of -3.93%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 19.04.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
ProQR Therapeutics N.V. | -7.166% | -7.166% |
iShares Core DAX® | -1.215% | 4.788% |
iShares Nasdaq 100 | -1.911% | 1.109% |
iShares Nikkei 225® | -3.171% | 5.626% |
iShares S&P 500 | -1.029% | 1.792% |
Comments by Citigroup_Inc_ for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its price target raised by analysts at Citigroup Inc. from $1.80 to $2.00. They now have a "buy" rating on the stock.
Ratings data for PRQR provided by MarketBeat